Abstract
High-density lipoprotein cholesterol has an important role in the pathophysiology of coronary artery disease. High-density lipoprotein cholesterol is becoming an increasingly important prognostic and therapeutic target. The purpose of this paper is to review the biochemical pathways involved in reverse cholesterol transport and to discuss potential, clinically based high-density lipoprotein therapies that may contribute to reduction in risk of atherosclerosis.
MeSH terms
-
ATP-Binding Cassette Transporters / metabolism
-
Anticholesteremic Agents / pharmacology
-
Biological Transport
-
Cholesterol Ester Transfer Proteins / antagonists & inhibitors
-
Cholesterol Ester Transfer Proteins / metabolism
-
Cholesterol, HDL / blood
-
Cholesterol, HDL / metabolism*
-
Coronary Artery Disease / blood
-
Coronary Artery Disease / prevention & control*
-
Humans
Substances
-
ATP-Binding Cassette Transporters
-
Anticholesteremic Agents
-
CETP protein, human
-
Cholesterol Ester Transfer Proteins
-
Cholesterol, HDL